JAK3/BTK-IN-3
CAT:
804-HY-143718
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
JAK3/BTK-IN-3
- CAS Number: 2674036-98-5
- UNSPSC Description: JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-3 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147952A1, compound 009)[1]
- Target Antigen: Btk; JAK
- Type: Reference compound
- Related Pathways: Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
- Applications: COVID-19-immunoregulation
- Field of Research: Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/jak3-btk-in-3.html
- Solubility: 10 mM in DMSO
- Smiles: CN(N=C1)C=C1NC2=NC(N[C@H]3CN([C@H](CC3)C)C(C=C)=O)=C4C(C5CC5)=CNC4=N2
- Molecular Weight: 420.51
- References & Citations: [1]Guobao Zhang, et al. Pyrimidopyrroles. Patent WO2021147952A1.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported